Zinc in PDB 4fgk: Oxidized Quinone Reductase 2 in Complex with Chloroquine
Enzymatic activity of Oxidized Quinone Reductase 2 in Complex with Chloroquine
All present enzymatic activity of Oxidized Quinone Reductase 2 in Complex with Chloroquine:
1.10.99.2;
Protein crystallography data
The structure of Oxidized Quinone Reductase 2 in Complex with Chloroquine, PDB code: 4fgk
was solved by
K.K.Leung,
B.H.Shilton,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
32.67 /
1.40
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
56.370,
83.110,
106.580,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
13.3 /
17.4
|
Other elements in 4fgk:
The structure of Oxidized Quinone Reductase 2 in Complex with Chloroquine also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Oxidized Quinone Reductase 2 in Complex with Chloroquine
(pdb code 4fgk). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Oxidized Quinone Reductase 2 in Complex with Chloroquine, PDB code: 4fgk:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 4fgk
Go back to
Zinc Binding Sites List in 4fgk
Zinc binding site 1 out
of 2 in the Oxidized Quinone Reductase 2 in Complex with Chloroquine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Oxidized Quinone Reductase 2 in Complex with Chloroquine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn303
b:22.3
occ:1.00
|
ND1
|
A:HIS173
|
2.0
|
18.1
|
1.0
|
O
|
A:CYS222
|
2.1
|
21.3
|
1.0
|
ND1
|
A:HIS177
|
2.1
|
21.4
|
1.0
|
SG
|
A:CYS222
|
2.3
|
20.4
|
1.0
|
HB3
|
A:CYS222
|
2.4
|
28.6
|
1.0
|
CB
|
A:CYS222
|
2.7
|
23.8
|
1.0
|
C
|
A:CYS222
|
2.9
|
26.3
|
1.0
|
HA
|
A:HIS173
|
2.9
|
17.0
|
1.0
|
CE1
|
A:HIS173
|
2.9
|
22.2
|
1.0
|
CG
|
A:HIS177
|
3.0
|
22.3
|
1.0
|
HB2
|
A:HIS177
|
3.1
|
23.1
|
1.0
|
CG
|
A:HIS173
|
3.1
|
17.6
|
1.0
|
HE1
|
A:HIS173
|
3.1
|
26.6
|
1.0
|
HB3
|
A:HIS177
|
3.1
|
23.1
|
1.0
|
CE1
|
A:HIS177
|
3.1
|
20.1
|
1.0
|
HB2
|
A:HIS173
|
3.2
|
18.5
|
1.0
|
CB
|
A:HIS177
|
3.3
|
19.3
|
1.0
|
HE1
|
A:HIS177
|
3.3
|
24.1
|
1.0
|
CA
|
A:CYS222
|
3.3
|
23.0
|
1.0
|
CB
|
A:HIS173
|
3.4
|
15.4
|
1.0
|
HB2
|
A:CYS222
|
3.6
|
28.6
|
1.0
|
CA
|
A:HIS173
|
3.7
|
14.2
|
1.0
|
HA
|
A:CYS222
|
3.8
|
27.6
|
1.0
|
N
|
A:THR223
|
4.0
|
24.2
|
1.0
|
NE2
|
A:HIS173
|
4.1
|
19.1
|
1.0
|
HA
|
A:THR223
|
4.1
|
27.5
|
1.0
|
CD2
|
A:HIS173
|
4.2
|
16.3
|
1.0
|
CD2
|
A:HIS177
|
4.2
|
22.4
|
1.0
|
NE2
|
A:HIS177
|
4.2
|
25.2
|
1.0
|
HE1
|
A:HIS227
|
4.2
|
21.6
|
1.0
|
O
|
A:HOH557
|
4.3
|
45.2
|
1.0
|
HE1
|
A:TYR132
|
4.3
|
16.9
|
0.6
|
HD1
|
A:TYR132
|
4.4
|
16.5
|
0.6
|
HB3
|
A:HIS173
|
4.4
|
18.5
|
1.0
|
N
|
A:CYS222
|
4.5
|
24.4
|
1.0
|
H
|
A:CYS222
|
4.6
|
29.3
|
1.0
|
CA
|
A:THR223
|
4.6
|
22.9
|
1.0
|
HZ3
|
A:TRP169
|
4.6
|
24.6
|
1.0
|
N
|
A:HIS173
|
4.6
|
14.2
|
1.0
|
H
|
A:THR223
|
4.6
|
29.1
|
1.0
|
C
|
A:HIS173
|
4.6
|
11.8
|
1.0
|
O
|
A:HIS173
|
4.7
|
14.6
|
1.0
|
O
|
A:GLN172
|
4.7
|
17.3
|
1.0
|
CE1
|
A:TYR132
|
4.8
|
14.1
|
0.6
|
CA
|
A:HIS177
|
4.8
|
18.6
|
1.0
|
CD1
|
A:TYR132
|
4.8
|
13.8
|
0.6
|
HE2
|
A:HIS173
|
4.8
|
22.9
|
1.0
|
O
|
A:HOH611
|
4.9
|
31.8
|
1.0
|
CE1
|
A:HIS227
|
5.0
|
18.0
|
1.0
|
C
|
A:GLN172
|
5.0
|
12.9
|
1.0
|
HE2
|
A:HIS177
|
5.0
|
30.3
|
1.0
|
|
Zinc binding site 2 out
of 2 in 4fgk
Go back to
Zinc Binding Sites List in 4fgk
Zinc binding site 2 out
of 2 in the Oxidized Quinone Reductase 2 in Complex with Chloroquine
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Oxidized Quinone Reductase 2 in Complex with Chloroquine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn301
b:11.7
occ:1.00
|
ND1
|
B:HIS173
|
2.0
|
11.4
|
1.0
|
O
|
B:CYS222
|
2.0
|
11.8
|
1.0
|
ND1
|
B:HIS177
|
2.1
|
13.4
|
1.0
|
SG
|
B:CYS222
|
2.3
|
11.5
|
1.0
|
HB3
|
B:CYS222
|
2.6
|
15.2
|
1.0
|
CB
|
B:CYS222
|
2.9
|
12.7
|
1.0
|
C
|
B:CYS222
|
2.9
|
11.7
|
1.0
|
HA
|
B:HIS173
|
2.9
|
11.9
|
1.0
|
CE1
|
B:HIS173
|
2.9
|
14.1
|
1.0
|
CG
|
B:HIS177
|
3.0
|
10.7
|
1.0
|
CG
|
B:HIS173
|
3.0
|
11.7
|
1.0
|
CE1
|
B:HIS177
|
3.1
|
13.4
|
1.0
|
HE1
|
B:HIS173
|
3.1
|
16.9
|
1.0
|
HB2
|
B:HIS177
|
3.1
|
11.6
|
1.0
|
HB3
|
B:HIS177
|
3.1
|
11.6
|
1.0
|
HB2
|
B:HIS173
|
3.1
|
12.5
|
1.0
|
HE1
|
B:HIS177
|
3.3
|
16.1
|
1.0
|
CB
|
B:HIS177
|
3.3
|
9.7
|
1.0
|
CB
|
B:HIS173
|
3.4
|
10.4
|
1.0
|
CA
|
B:CYS222
|
3.4
|
12.5
|
1.0
|
CA
|
B:HIS173
|
3.6
|
9.9
|
1.0
|
HB2
|
B:CYS222
|
3.7
|
15.2
|
1.0
|
HA
|
B:CYS222
|
4.0
|
15.0
|
1.0
|
N
|
B:THR223
|
4.0
|
12.7
|
1.0
|
NE2
|
B:HIS173
|
4.1
|
13.0
|
1.0
|
HA
|
B:THR223
|
4.1
|
15.3
|
1.0
|
CD2
|
B:HIS173
|
4.1
|
11.6
|
1.0
|
NE2
|
B:HIS177
|
4.2
|
12.7
|
1.0
|
CD2
|
B:HIS177
|
4.2
|
10.2
|
1.0
|
HE1
|
B:HIS227
|
4.3
|
12.6
|
1.0
|
HB3
|
B:HIS173
|
4.4
|
12.5
|
1.0
|
HE1
|
B:TYR132
|
4.5
|
12.8
|
1.0
|
N
|
B:HIS173
|
4.6
|
9.1
|
1.0
|
N
|
B:CYS222
|
4.6
|
12.6
|
1.0
|
CA
|
B:THR223
|
4.6
|
12.8
|
1.0
|
H
|
B:CYS222
|
4.6
|
15.1
|
1.0
|
HZ3
|
B:TRP169
|
4.6
|
16.5
|
1.0
|
C
|
B:HIS173
|
4.6
|
10.9
|
1.0
|
HD1
|
B:TYR132
|
4.6
|
13.9
|
1.0
|
O
|
B:HIS173
|
4.6
|
10.3
|
1.0
|
O
|
B:GLN172
|
4.7
|
9.4
|
1.0
|
H
|
B:THR223
|
4.7
|
15.3
|
1.0
|
O
|
B:HOH561
|
4.8
|
37.5
|
1.0
|
HE2
|
B:HIS173
|
4.8
|
15.6
|
1.0
|
CA
|
B:HIS177
|
4.8
|
9.3
|
1.0
|
C
|
B:GLN172
|
4.9
|
9.9
|
1.0
|
HE2
|
B:HIS177
|
4.9
|
15.2
|
1.0
|
HD2
|
B:HIS173
|
5.0
|
13.9
|
1.0
|
|
Reference:
K.K.Leung,
B.H.Shilton.
Crystal Structures of Quinone Reductase 2 Bound to Antimalarial Drugs Reveal Conformational Change Upon Reduction J.Biol.Chem. 2013.
ISSN: ESSN 1083-351X
Page generated: Sat Oct 26 22:26:23 2024
|